Navigation Links
Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
Date:3/4/2008

AUSTIN, TX and TORONTO, March 4 /PRNewswire/ - Affinium Pharmaceuticals today announced that they have commenced the dosing of healthy subjects in a Phase I study of AFN-1252, one of its lead clinical candidates from its novel class of fatty acid biosyntheis inhibitors. The study of AFN-1252 will evaluate the safety, tolerability and pharmacokinetics of a single escalating oral dose. Affinium believes that AFN-1252 will provide patients and their doctors a potent, oral and IV treatment for susceptible and resistant staphylococcal infections both in and out of hospitals.

AFN-1252 is an investigational antibiotic, with a novel mechanism of action, and very high potency against all drug-resistant phenotpyes of staphylococci including hospital and community-acquired MRSA. Oral bioavailability has previously been demonstrated in a human microdosing study and excellent in vivo efficacy has been demonstrated in various animal models of infection.

"Affinium is very pleased to advance this novel class of antibiotics with great potential to address the serious unmet medical need for new oral and IV antibiotics capable of treating multi-drug resistant staphylococcal infections," said Dr. Barry Hafkin, Chief Medical Officer of Affinium Pharmaceuticals. "In preclinical studies, AFN-1252 was well tolerated at high multiples of the projected human dose in two species, suggesting a safety profile that would be very attractive to physicians practicing both in and out of hospital settings." Dr. Hafkin added that "the specific-spectrum of activity of AFN-1252 may provide further safety advantages by decreasing the risk of gut and cutaneous flora disruption."

About Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the discovery, development and commercialization of novel anti-infective medicines. AFN-1252 utilizes a unique mechanism of action by directly inhibiting the function of the bacterial fatty ac
'/>"/>

SOURCE Affinium Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
2. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
3. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
4. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
5. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
6. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
7. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
8. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
9. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
10. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
11. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., N.J., Dec. 2 Watson Ph... that the Federal Trade Commission (FTC) has accep...lating to Watson,s pending acquisition of privatel...on of the Hart Scott Rodino waiting period, thereb... The parties have now obtained all regulatory app...
(Date:12/2/2009)... and REDMOND, Wash., Dec. 2 /PRNewswire/ -- Go...anies will collaborate to give caregivers single-p...necessary for providing ongoing care after patient...r families better tools for managing patients, hea...are organization to adopt Microsoft Amalga Unified...
(Date:12/2/2009)...t to death from TB, not Addison,s, researcher says... -- The woman behind Pride and Prejudice and E...ison,s disease, as has long been believed, says on...in 1817 at the age of 41, many historians and othe...sease, which affects the adrenal glands and create...
(Date:12/2/2009)... Bereaved families around the world will join tog... Candle Lighting Sunday, December 13 to remember a... the public will be held in the United States and ...d,s largest mass candle lighting. , ...- Tens of thousands of families around the world, ...
(Date:12/2/2009)... Experts outline practical approach to help organ...s to build business value and reduce costs. , ...er 2, 2009 —- The pressure to comply with mu...rofessionals than it is today. More than 75 percen...gulations and corresponding audits.¹ Without ...
Breaking Medicine News(10 mins):Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:New Light on Jane Austen's Final Chapter 2Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 2Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 3
... significantly reduce the ability of bacteria to c...ntly in the Journal of Agricultural and Food Chemi...ls, present in large amounts in fermented seeds an...ne grape-based chemicals may also hold clues for n...
...ts are more common in older adults because they ar...ly by these drugs than their younger counterparts....ol of Medicine clinicians, published in American F...r adults. , About one in three older persons taki...
...ions to treat patients with pain-related emergency...ients were more likely to receive opioids than pat...a study in the January 2 issue of JAMA. , In the...ed to be at higher risk of receiving inadequate tr...
... January 1 issue of the journal SLEEP finds that z...even nights per week for up to six months, provide...onset and maintenance, and also improved next-day ...ry insomnia, who had difficulty initiating or main...
...oung adults significantly decreases their ability ...isk of type 2 diabetes, report researchers at the ...Edition of the Proceedings of the National Academy..., but its significance for physical well-being has...
...syndrome (RLS) are twice as likely to have a strok... and the risk is greatest in those with the most f... published in the January 1, 2008, issue of Neurol...eople with an average age of 68 who were enrolled ...
Other Medicine News:Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 2Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 3Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 4Health News:Tips to prevent adverse drug events in older adults 2Health News:Tips to prevent adverse drug events in older adults 3Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 2Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 3Health News:Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia 2Health News:Lack of deep sleep may increase risk of type 2 diabetes 2Health News:Lack of deep sleep may increase risk of type 2 diabetes 3Health News:Restless legs syndrome doubles risk of stroke and heart disease 2
(Date:12/1/2009)... Calif., Dec. 1 Reproductive Partn...ingle Embryo Transfer (eSET) Encouragement Program...h good embryo quality and a good prognosis for suc...ransferring a single embryo. ,, The biggest iss...ducing the number of multiple pregnancies, even tw...
(Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, HPLC Systems & Acces...reportlinker.com/p0164366/HPLC-Systems--Accessorie...rs, Liquid Chromatography has emerged as a workhor...ood and beverage, research and development, and in...
(Date:12/1/2009)...UE, Wash., Dec. 1 drugst...etailer of health, beauty, vision, and pharmacy pr...best day ever as customer orders were the highest ...tore.com and Beauty.com web stores featured mor...largest gift selection yet. ,, (Logo: http://w...
Breaking Medicine Technology:Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Single women gaze longer 8706 1Single women gaze longer 8706 2Click4Care 28R 29 Announces Appointment of Rob Gillette as CEO 47784 1Click4Care 28R 29 Announces Appointment of Rob Gillette as CEO 47784 2Hill Rom to Present at the Jefferies 3rd Annual Healthcare Conference 47781 1
...mulation Has Benefits , , WASHINGTON, Jan. 13 El...n which a pacemaker-like device sends pulses to el... drug therapy but may hold significant benefits fo...pond well to medication alone. , , That is the co...erans Affairs (VA) and National Institutes of Heal...
...RNewswire-FirstCall/ - - Uroplasty, Inc. (Amex: ...f Macroplastique for the treatment of female stres...ry 2009 Journal of Urology . This is the first, l...afety and efficacy of Macroplastique to another bu...oplastique group, the dry/cure rate was 36.9% vers...
Other Medicine Technology:VA-NIH Study Offers Hope for Parkinson's Patients 2VA-NIH Study Offers Hope for Parkinson's Patients 3Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 2Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: